Pay to Marwadi

Company Profile

ASTEC LIFESCIENCES LTD.

NSE : ASTECBSE : 533138ISIN CODE : INE563J01010Industry : Pesticides & AgrochemicalsHouse : Godrej
BSE1265.658.95 (+0.71 % )
PREV CLOSE (Rs.) 1256.70
OPEN PRICE (Rs.) 1296.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3413
TODAY'S LOW / HIGH (Rs.)1244.45 1296.85
52 WK LOW / HIGH (Rs.)826.15 1540
NSE1261.55 4.55 (+0.36 % )
PREV CLOSE(Rs.) 1257.00
OPEN PRICE (Rs.) 1251.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 42401
TODAY'S LOW / HIGH(Rs.) 1241.35 1282.15
52 WK LOW / HIGH (Rs.)825.05 1541.65

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.12
TTM EPS (Rs.) -26.01
P/E Ratio 0.00
Book Value (Rs.) 188.72
Face Value (Rs.) 10
MCap (Rs. in Mn) 24818.39
Price/Earning (TTM) -155.82
Price/Sales (TTM) 5.75
Price/Book (MRQ) 6.71
PAT Margin (%) 4.04
ROCE (%) 7.75
Incorporation Year : 1994

Management Info :

- Chairman - Managing Director

Registered Office :

Address : Godrej One, 3rd Floor,Pirojshanagar, Eastern Express Highway ,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022-25188010

Registrar's Details : Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE
NEWS More
06Mar03-06-2024$ Clarification Sought from Astec Lifesciences Ltd Clarification Sought from A
The Exchange has sought clarification from Astec Lifesciences Ltd on March 6, 2024, with reference to Movement in Volume. The reply is awaited.
The Exchange has sought clarification from Astec Lifesciences L..
12Feb02-12-2024$Appointment of CEO Appointment of CEO
Inter alia, approved:- (a) RE-APPOINTMENT OF MR. ANURAG ROY (DIN: 07444595) AS THE ?WHOLE-TIME DIRECTOR & CHIEF EXECUTIVE OFFICER? FOR A FURTHER TERM OF 3 (THREE) YEARS WITH EFFECT FROM 28TH JULY, 2024 UPTO 27TH JULY, 2027, SUBJECT TO THE APPROVAL OF SHAREHOLDERS: The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee of the Board of Directors, has re-appointed Mr. Anurag Roy [Director Identification Number (DIN): 07444595] as the ?Whole Time Director & Chief Executive Officer? for a term of 3 (Three) years with effect from 28th July, 2024 upto 27th July, 2027 and approved the remuneration payable to him in such capacity. The re- appointment of Mr. Anurag Roy as the ?Whole Time Director & Chief Executive Officer? for a term of 3 (Three) years with effect from 28th July, 2024 upto 27th July, 2027 is subject to approval of the Shareholders of the Company.
Inter alia, approved:- (a) RE-APPOINTMENT OF MR. ANURAG ROY (D..
11Jan01-11-2024$Astec Lifesciences informs about compliances-certificate Astec Lifesciences informs a
Astec Lifesciences has enclosed compliance certificate received from Bigshare Services, Registrar and Share Transfer Agent of Astec LifeSciences, for the Quarter ended 31st December, 2023, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences has enclosed compliance certificate received..
23Aug08-23-2023$Astec Lifesciences raises Rs 49 crore through NCDs Astec Lifesciences raises Rs

Astec Lifesciences has raised Rs 49 crore through the allotment of 4,900 Rated, Listed, Unsecured, Redeemable, Non-Convertible Debentures (NCDs) having a face value of Rs 1,00,000 each, to an eligible investor. The Managing Committee of the Board of Directors of the Company at their meeting held on August 22, 2023, has allotted the same. 

Astec Lifesciences manufactures a wide range of agrochemicals and pharmaceutical intermediates.


Astec Lifesciences has raised Rs 49 crore through the allotment..
02Aug08-02-2023$Astec Lifesciences informs about disclosure Astec Lifesciences informs a

Astec Lifesciences has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences has informed that the exchange has received..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit-243.47255.19
Gross Profit -322.47 348.48
Operating Profit -174.29893
Net Sales 507.946281.66
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Bharat Rasayan (BSE)
 9522.95 (2.42%)
M.Cap ( in Cr)
3957.04
Bhagiradha Chem (BSE)
 1964.50 (11.98%)
M.Cap ( in Cr)
2044.16
Bayer CropScience (BSE)
 5550.05 (3.23%)
M.Cap ( in Cr)
24943.09
Dhanuka Agritech (BSE)
 1271.55 (4.21%)
M.Cap ( in Cr)
5795.51
Excel Industries (BSE)
 899.55 (4.21%)
M.Cap ( in Cr)
1130.80
Shareholding Pattern More
MUTUAL FUNDS/UTI 8.77 %
PROMOTERS 66.75 %
NON-INSTITUTION 22.23 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes